← Back to Home
Short Term·Markets Desk·Tue, 21 Jul
5 Short-Term Buys: DIAMINESQ, AMBUJACEM Backed by Research Desks
Research desks at Ndtv Profit and 3 other desks backed 5 stocks for short-term gains over the coming weeks, reflecting a broadly bullish market view.
By Markets Desk·19 Calls·19 Buy
Ndtv Profit and 3 other registered desks issued 19 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a bullish bias — 19 buys against 0 sells — covering 5 stocks.
DIAMINESQ was flagged for a buy by Ndtv Profit at ₹254.99, targeting ₹1,455.5 — a potential upside of +470.8%.
AMBUJACEM attracted 4 separate recommendations from registered analysts — Sislofficial issued a buy at ₹437 targeting ₹445 (stop ₹420); Sislofficial issued a buy at ₹437 targeting ₹455 (stop ₹420); Sislofficial issued a buy at ₹437 targeting ₹465 (stop ₹420); Cnbc Awaaz issued a buy at ₹441 targeting ₹460 (stop ₹434).
PFIZER was flagged for a buy by Ndtv Profit at ₹4,578.1.
Also covered: DABUR (₹423 → ₹452) via Ndtv Profit; CONCOR (₹493 → ₹534) via Ndtv Profit, Zee Business.
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Analyst Sources
Ndtv ProfitSislofficialCnbc AwaazZee Business
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.